Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rita Jain Insider Profile
11 Followers
Rita Jain, SVP, Chief Medical Officer at Akebia Therapeutics, holds 4.53K shares in AnaptysBio (Ticker: ANAB), holds 0.00 shares in ChemoCentryx (Ticker: CCXI), holds 129.37K shares in Immunovant (Ticker: IMVT).
Rita Jain has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rita Jain holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Rita Jain
Rita Jain's Trading History
Akebia Therapeutics
Apr 12, 2019
SVP, Chief Medical Officer
Uninformative Sell
33.95K
$130.05K
ChemoCentryx
Oct 24, 2022
―
Uninformative Sell
―
$0.00
Immunovant
Mar 23, 2021
CMO
Uninformative Buy
―
$3.62M
Provention Bio
―
―
―
―
Celldex
―
Director
―
―
AnaptysBio
Jun 18, 2024
Director
Uninformative Buy
107.77K
$152.80K
List of latest transactions for each holding click on a transaction to see Rita Jain's performance on stock
You May Also Like
Rita Jain insider profile FAQ
What is the percentage of profitable transactions made by Rita Jain?
The percentage of profitable transactions made by Rita Jain is ―.
What is the average return per transaction made by Rita Jain?
The average return per transaction made by Rita Jain is ―.
What stocks does Rita Jain hold?
Rita Jain holds: AKBA, CCXI, IMVT, PRVB, CLDX, ANAB stocks.
What was Rita Jain’s latest transaction?
Rita Jain latest transaction was an Uninformative Buy of $107.77K.
What was Rita Jain's most profitable transaction?
Rita Jain’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Rita Jain's role in Akebia Therapeutics?
Rita Jain's role in Akebia Therapeutics is SVP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.